Long‐term outcomes of cribriform‐positive and cribriform‐negative prostate cancer treated with radical prostatectomy in the ProtecT trial

Documenti analoghi

• Screening and active surveillance in prostate cancer: the dilemma continues
  di: Freddie C. Hamdy, et al.
  Pubblicazione: (2024)
• In‐field prostate cancer recurrence following radical prostatectomy and salvage radiation
  di: Austin Martin, et al.
  Pubblicazione: (2024)
• Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer
  di: Lies Van den Eynde, et al.
  Pubblicazione: (2025)
• The impact of prostate size on single‐port robot‐assisted radical prostatectomy surgical outcomes
  di: Alessio Finocchiaro, et al.
  Pubblicazione: (2026)
• Comment on ‘Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer’
  di: Kun Zhao, et al.
  Pubblicazione: (2025)